Menu Menu

HBIO    Harvard Bioscience Inc    1123494    
Income Statement
Revenue 21,969,000
Net Income -4,802,000
Profit Margin -21.86%

Balance Sheet
Current Assets 46,791,000
Assets 131,239,000
Current Liabilities 22,751,000
Liabilities 65,917,000
Equity 65,322,000
Shares Out 43,611,000

Cash Flow Statement
Operating Cash Flow -285,000
Investing Cash Flow -878,000

Market Analysis
Market Cap 127,779,822
Price 1.93
BVPS 1.50
PB 1.28
EPS -0.25
PS 1.45
FCF -1,163,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
3/07 2.28
Apr May Jun
5/07 0.02
Jul Aug Sep
8/08
Oct Nov Dec
11/05

Find a discrepancy? The most accurate way to find company fundamental data is to view HBIO documents filed with the SEC.


HBIO Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: